文献速递糖尿病

利用启动子聚焦的Capture-C将2型糖尿病效应基因关联至相关代谢细胞模型

Implicating type 2 diabetes effector genes in relevant metabolic cellular models using promoter-focused Capture-C.
PubMed 文献 · Diabetologia · 2024-09-06

该研究整合启动子聚焦的Capture-C、ATAC-seq和RNA-seq数据,在EndoC-BH1(胰腺β细胞)、HepG2(肝细胞)和SGBS(脂肪细胞)中表征染色质与表达谱,变异至基因分析在370个2型糖尿病风险位点提名810个候选效应基因,并在EndoC-BH1中敲低SMCO4可见胰岛素分泌显著增加。

要点

  • 在EndoC-BH1、HepG2和SGBS细胞中整合Capture-C、ATAC-seq和RNA-seq数据。
  • 变异至基因分析在370个2型糖尿病风险位点提名810个候选效应基因。
  • 敲低EndoC-BH1细胞SMCO4基因可见胰岛素分泌统计学显著增加。

核心结论

  • 研究结果为在可操作的细胞模型中比较组织特异性数据(而非相对困难的原代细胞设置)提供了资源。

研究设计与样本

  • 研究生成并整合高分辨率启动子聚焦的Capture-C、ATAC-seq和RNA-seq数据集,在EndoC-BH1(胰腺β细胞)、HepG2(肝细胞)和SGBS(脂肪细胞)多种与2型糖尿病相关的细胞系中表征染色质与表达谱。

主要发现

  • 变异至基因分析在370个2型糖尿病风险位点提名810个候选效应基因。
  • 使用分区连锁不平衡得分回归,观察到2型糖尿病和空腹血糖GWAS位点在EndoC-BH1细胞中启动子连接的推定顺式调控元件富集,以及空腹胰岛素GWAS位点在SGBS细胞中富集。
  • 在EndoC-BH1细胞中敲低SMCO4基因表达后,观察到胰岛素分泌统计学显著增加。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Genome-wide association studies (GWAS) have identified hundreds of type 2 diabetes loci, with the vast majority of signals located in non-coding regions; as a consequence, it remains largely unclear which 'effector' genes these variants influence. Determining these effector genes has been hampered by the relatively challenging cellular settings in which they are hypothesised to confer their effects. METHODS: To implicate such effector genes, we elected to generate and integrate high-resolution promoter-focused Capture-C, assay for transposase-accessible chromatin with sequencing (ATAC-seq) and RNA-seq datasets to characterise chromatin and expression profiles in multiple cell lines relevant to type 2 diabetes for subsequent functional follow-up analyses: EndoC-BH1 (pancreatic beta cell), HepG2 (hepatocyte) and Simpson-Golabi-Behmel syndrome (SGBS; adipocyte). RESULTS: The subsequent variant-to-gene analysis implicated 810 candidate effector genes at 370 type 2 diabetes risk loci. Using partitioned linkage disequilibrium score regression, we observed enrichment for type 2 diabetes and fasting glucose GWAS loci in promoter-connected putative cis-regulatory elements in EndoC-BH1 cells as well as fasting insulin GWAS loci in SGBS cells. Moreover, as a proof of principle, when we knocked down expression of the SMCO4 gene in EndoC-BH1 cells, we observed a statistically significant increase in insulin secretion. CONCLUSIONS/INTERPRETATION: These results provide a resource for comparing tissue-specific data in tractable cellular models as opposed to relatively challenging primary cell settings. DATA AVAILABILITY: Raw and processed next-generation sequencing data for EndoC-BH1, HepG2, SGBS_undiff and SGBS_diff cells are deposited in GEO under the Superseries accession GSE262484. Promoter-focused Capture-C data are deposited under accession GSE262496. Hi-C data are deposited under accession GSE262481. Bulk ATAC-seq data are deposited under accession GSE262479. Bulk RNA-seq data are deposited under accession GSE262480.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Wachowski NA, Pippin JA, Boehm K, et al. Implicating type 2 diabetes effector genes in relevant metabolic cellular models using promoter-focused Capture-C. Diabetologia. 2024. PMID: 39240351. doi:10.1007/s00125-024-06261-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。